Edgewise Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 53.6M |
| FY2023 | 63.7M |
| FY2024 | 92.4M |
| FY2025 | 102.9M |
| FY2026 | 107.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 53.6M |
| FY2023 | 63.7M |
| FY2024 | 92.4M |
| FY2025 | 102.9M |
| FY2026 | 107.3M |